<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03206840</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL17_0274</org_study_id>
    <nct_id>NCT03206840</nct_id>
  </id_info>
  <brief_title>Neural Correlates of Self</brief_title>
  <acronym>NeuCoSe</acronym>
  <official_title>The Neural Correlates of the &quot; Self &quot; in Altered States of Consciousness</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Despite the increasing popularity of mindfulness meditation and hypnosis in healthcare and in
      the general community the underlying neurobiological mechanisms are unclear. The change in
      the relationship between the self and the conscious experience that they bring about may be
      crucial. This study aims to identify the neural correlates of self-consciousness in
      meta-awareness and absorption - using functional Magnetic Resonance Imaging (fMRI) in healthy
      participants combined with detailed first-person experiential accounts and behavioural tasks.
      This study will provide important clues about the widely reported effects of mindfulness
      meditation and hypnosis and shed light on the neural correlates of the conscious experience
      of self.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 26, 2017</start_date>
  <completion_date type="Anticipated">October 26, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 26, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reaction time (minutes)</measure>
    <time_frame>at day 1</time_frame>
    <description>reaction times during behavioural tasks.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Brain activation with IRM</measure>
    <time_frame>At day 3</time_frame>
    <description>Activation of different brain areas, as measured with functional Magnetic Resonance</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>personality trait with questionnaires</measure>
    <time_frame>at day 2</time_frame>
    <description>scores on different personality questionnaires</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Scores during behavioural tasks</measure>
    <time_frame>at day 1</time_frame>
    <description>scores on likert scale (1-5 and 1-9) about intensity of the stimui presented during the task</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Scores during behavioural tasks</measure>
    <time_frame>at day 3</time_frame>
    <description>scores on likert scale (1-5 and 1-9) about intensity of the stimui presented during the task</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>salivary volume (millimeter)</measure>
    <time_frame>at day 1</time_frame>
    <description>salivary volume after behavioural tasks</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Healthy Volunteers</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>three instructions will be given to each participant: &quot;control&quot;, &quot;meditation&quot;, &quot;hypnosis&quot;. The order of &quot;meditation&quot; and &quot;hypnosis&quot; will be randomized amongst two groups to avoid order effects.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>three instructions will be given to each participant: &quot;control&quot;, &quot;meditation&quot;, &quot;hypnosis&quot;. The order of &quot;meditation&quot; and &quot;hypnosis&quot; will be randomized amongst two groups to avoid order effects.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>&quot;control&quot;, &quot;meditation&quot;, &quot;hypnosis&quot;.</intervention_name>
    <description>three instructions will be given to each participant: &quot;control&quot;, &quot;meditation&quot;, &quot;hypnosis&quot;. The order of &quot;meditation&quot; and &quot;hypnosis&quot; will be randomized amongst two groups to avoid order effects.</description>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_label>Group 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  aged 18-70

          -  Body mass index between 18.5 and 30

          -  Covered by health insurance

          -  motivated to participate

          -  signed informed consent

          -  normal or corrected-to-normal eyesight

          -  sufficient command of French to be able to follow the instructions

        Exclusion Criteria:

          -  history of neurological or psychiatric conditions

          -  chronic pain or another medical condition altering pain perception

          -  use of medication that affects the central nervous system

          -  use of opioids or antidepressant medication

          -  severe auditory loss

          -  consumption of alcohol or intoxicants on the day of the experiments and the day
             preceding the experiments

          -  pregnancy, breastfeeding or having given birth &lt;6months ago

          -  any contra-indication to Magnetic Resonance Imaging (metal implants or foreign
             bodies), agitation, claustrophobia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antoine LUTZ, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lyon Neuroscience Research Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Antoine LUTZ, PhD</last_name>
    <phone>4.72.13.89.08</phone>
    <phone_ext>+33</phone_ext>
    <email>antoine.lutz@inserm.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Prisca Bauer, MD, PhD</last_name>
    <phone>472 13 89 70</phone>
    <phone_ext>+33</phone_ext>
    <email>prisca.bauer@inserm.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospices Civils de Lyon HÃ´pital le Vinatier/Inserm</name>
      <address>
        <city>Bron</city>
        <zip>69500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antoine LUTZ, PhD</last_name>
      <phone>4.72.13.89.08</phone>
      <phone_ext>+33</phone_ext>
      <email>antoine.lutz@inserm.fr</email>
    </contact>
    <contact_backup>
      <last_name>Prisca Bauer, MD, PhD</last_name>
      <phone>4 72 13 89 70</phone>
      <phone_ext>+33</phone_ext>
      <email>prisca.bauer@inserm.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Julien JUNG, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 30, 2017</study_first_submitted>
  <study_first_submitted_qc>June 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 2, 2017</study_first_posted>
  <last_update_submitted>October 27, 2017</last_update_submitted>
  <last_update_submitted_qc>October 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>mindfulness meditation</keyword>
  <keyword>hypnosis</keyword>
  <keyword>meta-awareness</keyword>
  <keyword>absorption</keyword>
  <keyword>consciousness</keyword>
  <keyword>self</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

